Company Profile
New England Peptide is built around the vision of providing quality peptides and the highest level of customer satisfaction in the industry.The BEST ProductsPut simply, NEP will never compromise on the quality of our products. We understand the importance of your research and realize that the accuracy of your experiments is directly dependent on the reliability of our peptides. Therefore, we buy only the finest chemicals and the best instrumentation and have instituted a rigorous set of quality control protocols throughout the peptide manufacturing process in our state-of-the-art facility.NEP leverages its years of expertise in custom synthesis to get your order done and done right. For example, NEP uses the PepTrend? system, a unique software program designed and written by NEP to facilitate the design and synthesis of custom peptides and avoid synthesis complications.In order to document the quality of each order, we include a certificate of analysis with complete detailed information on all relevant instruments, analytical methods, chemical lot numbers and QC procedures as well as solubility suggestions for each individual peptide. The Best ServiceTo us, getting your order done correctly is the requirement. Getting it done quickly and supporting you with superior customer service is how we measure our true success. Typically, custom peptides ship within 2 to 3 weeks.One specific thing for which we will not sacrifice product quality is meeting a deadline. As is true of any scientific experiment, the element of unexpectedness does sometimes occur in our processes. We pride ourselves on being completely forthright with our customers and practice proactive customer service if we foresee any problems with an order.We also pride ourselves on providing personal and expert customer service, the kind of service you’d expect from a quality American company. You should expect to speak with a scientist who understands the technical nature of your questions, not just an administrative customer service representative.The Best RelationshipsAt NEP we believe in fostering deep and lasting relationships, not just with our customers, but with our vendors and with our employees. Because we rely on the quality of our raw materials, over the course of years, we have selected vendors who will ensure that we can provide the highest quality products. We also invest heavily in the training of our employees and in providing a positive working environment in which high quality and rapid turnaround time is the norm.Ultimately, our performance and our success will be judged by our customers and, therefore, our goal is to build relationships beyond the normal vendor/customer affiliation. We seek to build strategic partnerships with our customers and have them consider us as part of their business.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(ALA1)-PAR-4 (1-6) (MOUSE) |
PROTEINASE ACTIVATED RECEPTOR 4 AGONIST PEPTIDE (AYPGKF), MOUSE;PAR-4 AGONIST PEPTIDE (AYPGKF), MOUSE;AYPGKF;H-ALA-TYR-PRO-GLY-LYS-PHE-OH;H2N-AYPGKF-OH;CHORISMATE MUTASE (54-59) [CLOSTRIDIUM TETANI E88];(ALA1)-THROMBIN RECEPTOR-LIKE 3 (1-6) (MOUSE);(ALA1)-PROTEINASE ACTIVATED RECEPTOR 4 (1-6) (MOUSE) |
380900-00-5 | Inquiry | |
ANGIOTENSIN 1/2 + A (2 - 8) |
ANGIOTENSIN 1/2 + A (2 - 8);H2N-ARVYIHPF-OH;(ALA1)-ANGIOTENSIN II;ALA-ANGIOTENSIN III;H-ALA-ARG-VAL-TYR-ILE-HIS-PRO-PHE-OH;Ala-Angiotensin III, (Ala1)-Angiotensin II |
51833-76-2 | Inquiry | |
ANGIOTENSIN I, HUMAN |
ANGI;DRVYIHPFHL;ANGIOTENSINI;human,mouse,rat;H2N-DRVYIHPFHL-OH;ANGIOTENSI,HUMAN;AngiotensinI【rat】;Angiotensin-(1-10);HYPERTENSINIHUMAN;ANGIOTENSINI,HUMAN |
484-42-4 | Inquiry | |
ANGIOTENSIN I/II (1-5) |
ASP-ARG-VAL-TYR-ILE;ANGIOTENSIN (1-5);ANGIOTENSIN 1/2 (1-5);ANGIOTENSIN I/II (1-5);DRVYI;H-ASP-ARG-VAL-TYR-ILE-OH;H2N-DRVYI-OH |
58442-64-1 | Inquiry | |
ANGIOTENSIN I/II (1-6) |
ANGIOTENSIN I/II (1-6);ANGIOTENSIN 1/2 (1-6);H2N-DRVYIH-OH;H-ASP-ARG-VAL-TYR-ILE-HIS-OH;ASP-ARG-VAL-TYR-ILE-HIS |
47896-63-9 | Inquiry | |
ARG-GLY-ASP |
L-Aspartic acid,L-arginylglycyl-;L-Aspartic acid,N-(N-L-arginylglycyl)-;L-Arginylglycyl-L-aspartic acid;Arginylglycylaspartic acid;Arg-Gly-Asp;Arginine-glycine-aspartic acid;81: PN: US6001965 SEQID: 81 claimed protein;1: PN: WO0004941 PAGE: 31 claimed protein;1: PN: US6084066 SEQID: 1 claimed protein;1: PN: WO0045856 PAGE: 199 claimed protein;13: PN: US6147189 SEQID: 1 claimed protein;1: PN: WO0147553 PAGE: 13 claimed protein;4: PN: WO0147549 PAGE: 19 claimed protein;503: PN: WO0183525 TABLE: 9 claimed protein;49: PN: US6465427 PAGE: 134 claimed protein;3: PN: JP2002369878 PAGE: 2 claimed protein;3: PN: US6521211 PAGE: 151 claimed protein;51: PN: WO03027151 PAGE: 64 claimed protein;2: PN: JP2003038633 PAGE: 1 claimed protein;73: PN: WO03044045 SEQID: 74 claimed protein;2: PN: US20030113478 SEQID: 2 claimed protein;10: PN: JP2003189848 PAGE: 2 claimed protein;23: PN: WO03070749 PAGE: 36 claimed protein;70: PN: WO03072542 SEQID: 75 claimed protein;1: PN: WO03084980 SEQID: 5 claimed protein;9: PN: US20030211141 SEQID: 9 unclaimed protein;10: PN: WO2004013310 PAGE: 14 claimed protein;2: PN: WO2004058305 PAGE: 39 claimed protein;4: PN: WO2004071545 PAGE: 20 claimed protein;24: PN: US6797807 PAGE: 59-60 claimed protein;2: PN: JP2004344469 SEQID: 2 claimed protein;1: PN: WO2005027990 SEQID: 1 claimed protein;68: PN: WO2005118642 SEQID: 147 claimed protein;122106-47-2 |
99896-85-2 | Inquiry | |
ASP-ARG-VAL-TYR-ILE-HIS-PRO |
angiotensinii(1-7;H2N-DRVYIHP-OH;H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-OH;(DES-PHE8) ANGIOTENSIN II;DRVYIHP;ANGIOTENSIN (HUMAN, 1-7) (CANINE, RAT);ANGIOTENSIN (1-7);ANGIOTENSIN CANINE RAT |
51833-78-4 | Inquiry | |
ENFUVIRTIDE |
T-20;AC-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-AMIDE;AC-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2;AC-TYR-THR-SER-LEU-ILE-HIS-SER-LEU-ILE-GLU-GLU-SER-GLN-ASN-GLN-GLN-GLU-LYS-ASN-GLU-GLN-GLU-LEU-LEU-GLU-LEU-ASP-LYS-TRP-ALA-SER-LEU-TRP-ASN-TRP-PHE-NH2;ENFUVIRTIDE (T-20);ENVELOPE GLYCOPROTEIN FRAGMENT ACETYL/AMIDE[HUMAN IMMUNODEFICIENCY VIRUS 1];CH3CO-TYR-THR-SER-LEU-ILE-HIS-SER-LEU-ILE-GLU-GLU-SER-GLN-ASN-GLN-GLN-GLU-LYS-ASN-GLU-GLN-GLU-LEU-LEU-GLU-LEU-ASP-LYS-TRP-ALA-SER-LEU-TRP-ASN-TRP-PHE-NH2;5-Cyclohexyl-5-(tetrahydrothiophen-3-yl)hydantoin |
74038-65-6 | Inquiry | |
EXPERIMENTAL ALLERGIC ENCEPHALITOGENIC PEPTIDE (HUMAN) |
29705-92-8;Experimental Allergic Encephalitogenic Peptide (human);H-Phe-Ser-Trp-Gly-Ala-Glu-Gly-Gln-Arg-OH;L-Arginine,L-phenylalanyl-L-seryl-L-tryptophylglycyl-L-alanyl-L-a-glutamylglycyl-L-glutaminyl- |
29705-92-8 | Inquiry | |
Glycyl-glycyl-glycine |
Glycine,glycylglycyl-;Glycine,N-(N-glycylglycyl)-;Glycylglycylglycine;Triglycine;Diglycylglycine;N-(N′-Glycylglycyl)glycine;NSC 46707;Glycine tripeptide;Adenosine deaminase 2 (synthetic human derivative sequence variant);24: PN: WO2019213446 SEQID: 63 claimed protein;58: PN: WO2019213442 SEQID: 63 claimed protein;12: PN: WO2020022782 SEQID: 12 claimed protein;2-[2-(2-Aminoacetamido)acetamido]acetic acid;2-[[2-[(2-Azaniumylacetyl)amino]acetyl]amino]acetate;8: PN: WO2020135804 PAGE: 42 claimed sequence;3: PN: WO2020191289 PAGE: 118 claimed sequence;2: PN: WO2021011474 SEQID: 15 claimed protein;3: PN: KR20200139635 PAGE: 3 claimed sequence;18: PN: WO2021026491 SEQID: 21 claimed protein;23: PN: WO2021030484 SEQID: 23 claimed protein;15: PN: WO2021041934 SEQID: 68 claimed protein;171920-35-7;1361396-97-5 |
556-33-2 | Inquiry | |
H-ARG-LYS-ARG-SER-ARG-ALA-GLU-OH |
H2BTIDE;RKRSRAE;GLASSTIDE;PKG SUBSTRATE;H2N-RKRSRAE-OH;PKG SUBSTATE [RKRSRAE];ARG-LYS-ARG-SER-ARG-ALA-GLU;[ALA34]-HISTONE H2B (29-35);H-ARG-LYS-ARG-SER-ARG-ALA-GLU-OH;SUBSTRATE FOR CGMP PROTEIN KINASE |
81187-14-6 | Inquiry | |
H-ARG-PHE-ALA-ARG-LYS-GLY-ALA-LEU-ARG-GLN-LYS-ASN-VAL-HIS-GLU-VAL-LYS-ASN-OH |
113731-96-7 | Inquiry | ||
H-ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2 |
208041-90-1 | Inquiry | ||
H-ASN-ALA-PRO-VAL-SER-ILE-PRO-GLN-OH |
211439-12-2 | Inquiry | ||
H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-OH |
ANGIOTENSIN 1/2 (1-9);ANGIOTENSIN (1-9);ANGIOTENSIN I (1-9);H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-HIS-OH;H2N-DRVYIHPFH-OH;DRVYIHPFH;Des-Leu angiotensin I【human】;L-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-L-His-OH |
34273-12-6 | Inquiry | |
H-GLU-ALA-ASP-PRO-THR-GLY-HIS-SER-TYR-OH |
144449-86-5;MAGE-1 Antigen (161-169) (human);1w72;Mage-1 antigen(161-169)(human);ZINC195757859 |
144449-86-5 | Inquiry | |
H-GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU-OH |
141368-69-6;Matrix Protein M1 (58-66) (Influenza A virus);CEF1, Influenza Matrix Protein M1 (58-66);CHEMBL1869460;HY-P0137;ZINC150355093;NCGC00167248-01;CS-0019779;Matrix protein m1(58-66)(influenza a virus) |
141368-69-6 | Inquiry | |
H-GLY-TYR-PRO-GLY-LYS-PHE-NH2 |
245443-52-1 | Inquiry | ||
H-ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG-OH |
OVA (323-339);ISQAVHAAHAEINEAGR;H2N-ISQAVHAAHAEINEAGR-OH;OVALBUMIN CHICKEN (323-339);OVA (323-339) (CHICKEN, JAPANESE QUAIL);OVALBUMIN (323-339) (CHICKEN, JAPANESE QUAIL);ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG;H-ILE-SER-GLN-ALA-VAL-HIS-ALA-ALA-HIS-ALA-GLU-ILE-ASN-GLU-ALA-GLY-ARG-OH;OvalbuMin (323-339) (chicken, japanese quail)OVA (323-339) (chicken, japanese quail) |
92915-79-2 | Inquiry | |
H-ILE-THR-ASP-GLN-VAL-PRO-PHE-SER-VAL-OH |
162558-10-3 | Inquiry |